Exosomal miRNAs as biomarkers for diagnostic and prognosticin lung cancer

被引:64
作者
Wu, Jing [1 ]
Shen, Zuojun [1 ,2 ]
机构
[1] Anhui Med Univ, Anhui Prov Hosp, Dept Clin Lab, 17 Lu Jiang Rd, Hefei 230001, Anhui, Peoples R China
[2] Univ Sci & Technol China, Affliated Hosp 1, Div Life Sci & Med, Dept Clin Lab, Hefei, Anhui, Peoples R China
关键词
biomarker; diagnostic; exosomal miRNA; lung cancer; non-coding RNA; prognostic; EXTRACELLULAR VESICLES; POTENTIAL BIOMARKER; PLASMA; MARKERS; ADENOCARCINOMA; EXPRESSION; ANGIOGENESIS; METASTASIS; MICRORNAS; LAVAGE;
D O I
10.1002/cam4.3379
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
More and more studies report that exosomes released by various cells can serve as a medium for information exchange between different cells. Through a deep understanding of the physical and chemical properties of exosomes, the researchers revealed a more precise molecular mechanism of its participation in the process of intercellular communication. In particular, microRNA (miRNA) is found inside exosomes, as well as long noncoding RNA (lncRNA). Extensive evidence indicates that exosomal miRNAs participates in the occurrence and development of lung cancer and plays a variety of roles. Therefore, the release of RNA-containing exosomes in many different kinds of body fluids has caused widespread interest among researchers. In this review, we report evidence from human studies involving miRNAs and other ncRNAs in exosomes associated with lung cancer as diagnostic and prognostic markers. Currently, there is a small amount of evidence that exosomal miRNAs can be used as early diagnosis and prognostic markers for lung cancer, and their exact role in lung cancer patients still needs further study.
引用
收藏
页码:6909 / 6922
页数:14
相关论文
共 95 条
[91]   Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer [J].
Zhang, Yan ;
Li, Min ;
Hu, Chengping .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 507 (1-4) :457-464
[92]   Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients [J].
Zhang, Yi ;
Zhang, Yingmei ;
Yin, Yunhong ;
Li, Shuhai .
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (08)
[93]   Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location [J].
Zhong, Min-Er ;
Chen, Yanyu ;
Xiao, Yi ;
Xu, Lai ;
Zhang, Guannan ;
Lu, Junyang ;
Qiu, Huizhong ;
Ge, Wei ;
Wu, Bin .
EBIOMEDICINE, 2019, 50 :211-223
[94]   Integrated Microfluidic Device for Accurate Extracellular Vesicle Quantification and Protein Markers Analysis Directly from Human Whole Blood [J].
Zhou, Sisi ;
Hu, Tao ;
Zhang, Fen ;
Tang, Dezhi ;
Li, Dake ;
Cao, Jian ;
Wei, Wei ;
Wu, Yafeng ;
Liu, Songqin .
ANALYTICAL CHEMISTRY, 2020, 92 (01) :1574-1581
[95]   A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis [J].
Zhou, Xin ;
Wen, Wei ;
Shan, Xia ;
Zhu, Wei ;
Xu, Jing ;
Guo, Renhua ;
Cheng, Wenfang ;
Wang, Fang ;
Qi, Lian-Wen ;
Chen, Yan ;
Huang, Zebo ;
Wang, Tongshan ;
Zhu, Danxia ;
Liu, Ping ;
Shu, Yongqian .
ONCOTARGET, 2017, 8 (04) :6513-6525